echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tianjin Boai Biopharmaceuticals fined 3.01 million yuan for producing counterfeit drugs, legal representative was banned for life

    Tianjin Boai Biopharmaceuticals fined 3.01 million yuan for producing counterfeit drugs, legal representative was banned for life

    • Last Update: 2021-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the 20th, the administrative penalty document published by the Tianjin Medical and Drug Administration showed that Tianjin Boai Bio-Pharmaceutical Co.


    The administrative penalty document shows that Tianjin Boai Bio-Pharmaceutical Co.


    It is worth noting that from April 2020 to April 2021, Tianjin Boai Biopharmaceutical Co.


    In addition, according to the data, in July 2020, the raw milk (batch number 190501) produced by Tianjin Boai Biopharmaceutical Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.